Remote cognitive-behavioral therapy for generalized anxiety disorder: A preliminary meta-analysis.
anxiety
cognitive behavioral therapy
generalized anxiety disorder
meta-analysis
remote treatment
Journal
Journal of clinical psychology
ISSN: 1097-4679
Titre abrégé: J Clin Psychol
Pays: United States
ID NLM: 0217132
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
revised:
11
02
2022
received:
02
11
2021
accepted:
17
03
2022
pubmed:
12
4
2022
medline:
19
11
2022
entrez:
11
4
2022
Statut:
ppublish
Résumé
Generalized anxiety disorder (GAD) is a chronic mental health condition that results in significant individual, societal, and economic burden. While cognitive behavioral therapy (CBT) is well established as an efficacious treatment for GAD, individuals have identified several logistical barriers to accessing face-to-face CBT. Remotely delivered treatments address many of these treatment barriers. The aim of the current study was to synthesize the current literature on the efficacy of remote CBT for GAD using a meta-analytic approach. Relevant articles were identified through an electronic database search and 10 studies (with 11 remote conditions and 1071 participants) were included in the meta-analysis. Within-group findings indicate that remote CBT for GAD results in large effect sizes from pretreatment to posttreatment (g = 1.30; 95% confidence interval [CI]: 1.03-1.58). Both low intensity and high intensity remote CBT interventions were found to result in large effect sizes (g = 1.36; 95% CI: 1.11-1.61 and g = 0.83; 95% CI: 0.20-1.47, respectively), with no significant differences between the treatment formats (Q These findings have potential implications for the delivery of evidence-based treatment for GAD and the inclusion of remote methods in stepped care treatment approaches.
Sections du résumé
BACKGROUND
Generalized anxiety disorder (GAD) is a chronic mental health condition that results in significant individual, societal, and economic burden. While cognitive behavioral therapy (CBT) is well established as an efficacious treatment for GAD, individuals have identified several logistical barriers to accessing face-to-face CBT. Remotely delivered treatments address many of these treatment barriers.
METHODS
The aim of the current study was to synthesize the current literature on the efficacy of remote CBT for GAD using a meta-analytic approach. Relevant articles were identified through an electronic database search and 10 studies (with 11 remote conditions and 1071 participants) were included in the meta-analysis.
RESULTS
Within-group findings indicate that remote CBT for GAD results in large effect sizes from pretreatment to posttreatment (g = 1.30; 95% confidence interval [CI]: 1.03-1.58). Both low intensity and high intensity remote CBT interventions were found to result in large effect sizes (g = 1.36; 95% CI: 1.11-1.61 and g = 0.83; 95% CI: 0.20-1.47, respectively), with no significant differences between the treatment formats (Q
CONCLUSIONS
These findings have potential implications for the delivery of evidence-based treatment for GAD and the inclusion of remote methods in stepped care treatment approaches.
Identifiants
pubmed: 35403706
doi: 10.1002/jclp.23360
pmc: PMC9790363
doi:
Types de publication
Meta-Analysis
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2381-2395Informations de copyright
© 2022 The Authors. Journal of Clinical Psychology published by Wiley Periodicals LLC.
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Anxiety Disord. 2021 Apr;79:102385
pubmed: 33774557
J Med Internet Res. 2009 Apr 24;11(2):e13
pubmed: 19403466
J Anxiety Disord. 2018 Apr;55:70-78
pubmed: 29422409
J Pediatr Psychol. 2009 Oct;34(9):917-28
pubmed: 19223279
J Behav Ther Exp Psychiatry. 2021 Mar;70:101609
pubmed: 32950939
Psychol Serv. 2020 Feb;17(1):5-12
pubmed: 30070552
Cogn Behav Ther. 2011;40(3):216-27
pubmed: 21770844
Fam Pract. 2019 Jan 25;36(1):53-63
pubmed: 30188992
JAMA Psychiatry. 2017 May 1;74(5):465-475
pubmed: 28297020
PLoS One. 2010 Jun 03;5(6):e10942
pubmed: 20532167
Behav Res Ther. 1990;28(6):487-95
pubmed: 2076086
Depress Anxiety. 2020 Dec;37(12):1168-1178
pubmed: 32725848
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Psychother Psychosom. 2012;81(6):344-55
pubmed: 22964540
Pharmacoeconomics. 2020 Jan;38(1):25-37
pubmed: 31646432
Psychol Serv. 2019 Nov;16(4):621-635
pubmed: 29809025
Psychother Psychosom. 2015;84(1):61-2
pubmed: 25547039
J Clin Psychol. 2022 Dec;78(12):2381-2395
pubmed: 35403706
J Anxiety Disord. 2015 Dec;36:63-77
pubmed: 26460536
Cogn Behav Ther. 2011;40(3):159-73
pubmed: 21770848
Clin Psychol Rev. 2016 Feb;43:103-13
pubmed: 26494179
Br J Psychiatry. 1987 Oct;151:535-42
pubmed: 3328992
JAMA Psychiatry. 2015 Oct;72(10):1012-20
pubmed: 26244854
Depress Anxiety. 2018 Jun;35(6):502-514
pubmed: 29451967
Behav Res Ther. 2008 Mar;46(3):296-321
pubmed: 18258216
J Anxiety Disord. 2014 Dec;28(8):884-93
pubmed: 25445078
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120